Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae

Obstructive Lesions of Arteriovenous Dialysis Fistulae Clinical Trial

Official title: The Use of NMB Drug Ejecting Balloon for Arteriovenous (AV) Dialysis Fistulae

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) Balloon.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Fistula
• Obstructive Lesions of Arteriovenous Dialysis Fistulae

• NCT number: NCT01538108
• Study type: Interventional
• Source: N.M.B. Medical Applications Ltd
• Contact: Uri Rimon, MD
• Phone: 972-3-5302530
• Email: Uri.Rimon@sheba.health.gov.il
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2012
• Completion date: July 2014